×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Pr Jérôme Alexandre & Dr Enora Laas


Cas clinique :  

18:30
Mise en pratique des données de DESKTOP III :

 - Recommandations de surveillance à la fin du traitement initial - Pr Jérôme Alexandre

- Nouvelles stratégies chirurgicales en rechute - Dr Enora Laas
 
19:10
Espérance de vie des patientes sous iPARP : quels nouveaux enjeux en maintenance ?
Dr Manuel Rodrigues
 
19:35
Quelles possibilités de suivi des patientes sous iPARP en pratique courante ?
Mme Pascale Dielenseger
19:45
Discussion Q&A
 

 

Shooting date : 2021-06-22
Last update : 2021-06-29
1 comment
Join the Discussion
  • l D. quand pourra-t-on avoir le replay? Merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    0
    Days
    0
    Hours
    0
    Minutes
    0
    Seconds
    Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
    Honolulu : Monday, April 28th 2025 from 06:30am to 07:30am (GMT+2)
    San Francisco : Monday, April 28th 2025 from 09:30am to 10:30am (GMT+2)
    New York : Monday, April 28th 2025 from 12:30pm to 01:30pm (GMT+2)
    Buenos Aires : Monday, April 28th 2025 from 01:30pm to 02:30pm (GMT+2)
    Reykjavik : Monday, April 28th 2025 from 04:30pm to 05:30pm (GMT+2)
    London / Dublin : Monday, April 28th 2025 from 05:30pm to 06:30pm (GMT+2)
    Paris / Berlin : Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
    Istanbul : Monday, April 28th 2025 from 07:30pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Monday, April 28th 2025 from 08:30pm to 09:30pm (GMT+2)
    Bangkok : Monday, April 28th 2025 from 11:30pm to 12:30am (GMT+2)
    Shanghai : Tuesday, April 29th 2025 from 12:30am to 01:30am (GMT+2)
    Tokyo : Tuesday, April 29th 2025 from 01:30am to 02:30am (GMT+2)
    Sydney : Tuesday, April 29th 2025 from 03:30am to 04:30am (GMT+2)
    Wellington : Tuesday, April 29th 2025 from 05:30am to 06:30am (GMT+2)

    PARPi dans le cancer de l'ovaire en 1L

    données actuelles et perspectives pour la combinaison avec l’IO

    Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
    Honolulu : Wednesday, May 18th 2022 from 06:30am to 08am (GMT+2)
    San Francisco : Wednesday, May 18th 2022 from 09:30am to 11am (GMT+2)
    New York : Wednesday, May 18th 2022 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Wednesday, May 18th 2022 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Wednesday, May 18th 2022 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Wednesday, May 18th 2022 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
    Istanbul : Wednesday, May 18th 2022 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Wednesday, May 18th 2022 from 08:30pm to 10pm (GMT+2)
    Bangkok : Wednesday, May 18th 2022 from 11:30pm to 01am (GMT+2)
    Shanghai : Thursday, May 19th 2022 from 12:30am to 02am (GMT+2)
    Tokyo : Thursday, May 19th 2022 from 01:30am to 03am (GMT+2)
    Sydney : Thursday, May 19th 2022 from 03:30am to 05am (GMT+2)
    Wellington : Thursday, May 19th 2022 from 05:30am to 07am (GMT+2)

    Importance de la chimio-sensibilité dans la prise en charge des cancers de l’ovaire

    Share
    Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Monday, November 28th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Monday, November 28th 2022 from 08am to 09:30am (GMT+1)
    New York : Monday, November 28th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Monday, November 28th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Monday, November 28th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Monday, November 28th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Monday, November 28th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Tuesday, November 29th 2022 from 04am to 05:30am (GMT+1)

    Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022

    Share
    Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, January 31st 2024 from 06am to 07:30am (GMT+1)
    San Francisco : Wednesday, January 31st 2024 from 08am to 09:30am (GMT+1)
    New York : Wednesday, January 31st 2024 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Wednesday, January 31st 2024 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Wednesday, January 31st 2024 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Wednesday, January 31st 2024 from 05pm to 06:30pm (GMT+1)
    Istanbul : Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, January 31st 2024 from 08pm to 09:30pm (GMT+1)
    Bangkok : Wednesday, January 31st 2024 from 11pm to 12:30am (GMT+1)
    Shanghai : Thursday, February 1st 2024 from 12am to 01:30am (GMT+1)
    Tokyo : Thursday, February 1st 2024 from 01am to 02:30am (GMT+1)
    Sydney : Thursday, February 1st 2024 from 02am to 03:30am (GMT+1)
    Wellington : Thursday, February 1st 2024 from 04am to 05:30am (GMT+1)

    KELIM ou comment optimiser l’utilisation du CA 125 dans la prise en charge du cancer de l’ovaire...

    Share
    Scroll Up